Patent details
EP3827845 Title: SUBCUTANEOUS FORMULATIONS OF ANTI-CD38 ANTIBODIES AND THEIR USES
Basic Information
- Publication number:
- EP3827845
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP202158796
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- SUBCUTANEOUS FORMULATIONS OF ANTI-CD38 ANTIBODIES AND THEIR USES
- French Title of Invention:
- FORMULATIONS SOUS-CUTANÉES D'ANTICORPS ANTI-CD38 ET LEURS UTILISATIONS
- German Title of Invention:
- SUBKUTANE FORMULIERUNGEN VON ANTI-CD38-ANTIKÖRPERN UND DEREN VERWENDUNGEN
- SPC Number:
Dates
- Filing date:
- 01/11/2016
- Grant date:
- 30/03/2022
- EP Publication Date:
- 02/06/2021
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 30/03/2022
- EP B1 Publication Date:
- 30/03/2022
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 01/11/2036
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 23/03/2022
- Name:
- Janssen Biotech, Inc.
- Address:
- 800/850 Ridgeview Drive, Horsham, PA 19044, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 31/03/2022
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- KUMAR, Vineet
- Address:
- United States (US)
2
- Name:
- JANSSON, Richard
- Address:
- United States (US)
Priority
- Priority Number:
- 201562250016 P
- Priority Date:
- 03/11/2015
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 39/395; A61K 31/4439; A61K 31/198; A61K 31/573; A61K 31/69; C07K 16/28; A61K 9/10; A61K 47/12; A61K 47/20; A61K 47/22; A61P 35/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202213
- Publication date:
- 30/03/2022
- Description:
- Grant (B1)
2
- Issue number:
- 202218
- Publication date:
- 04/05/2022
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 01/12/2025
- Annual Fee Number:
- 10
- Annual Fee Amount:
- 131 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 25/10/2024
- Last Annual Fee Paid Number:
- 9
- Last Annual Fee Paid Amount:
- 115 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 31/03/2022 | Outgoing Correspondence | 1 |
| 31/03/2022 | Power Of Attorney | 1 |